Home hover Guidelines hover Expert hover Compare hover Faq hover Submit hover About hover Resources hover Syntheses hover Myngc hover Guidelinematrix hover
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 905   Next >
 
2.  
Recommendations for drug therapies for relapsing-remitting multiple sclerosis. 2013 Oct. NGC:010418
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
3.  
Management of chronic venous leg ulcers. A national clinical guideline. 1998 Jul (revised 2010 Aug). NGC:008077
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Drug treatment. In: Guidelines on urinary incontinence. 2009 Mar (revised 2013 Mar). NGC:010136
European Association of Urology - Medical Specialty Society. View all guidelines by the developer(s)
7.  
Drug allergy: an updated practice parameter. 2010 Oct. NGC:009335
American Academy of Allergy, Asthma and Immunology - Medical Specialty Society; American College of Allergy, Asthma and Immunology - Medical Specialty Society; Joint Council of Allergy, Asthma and Immunology - Medical Specialty Society. View all guidelines by the developer(s)
8.  
9.  
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. 2012 Sep. NGC:009487
European Heart Rhythm Association - Professional Association; Heart Rhythm Society - Professional Association. View all guidelines by the developer(s)
12.  
HIV drug - drug interactions. 2004 (revised 2010 Apr). NGC:007756
New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by the developer(s)
14.  
Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes. 2010 Aug (revised 2013 Jul). NGC:009997
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
15.  
Dapagliflozin in combination therapy for treating type 2 diabetes. 2013 Jun. NGC:009946
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Interagency guideline on opioid dosing for chronic non-cancer pain: an educational aid to improve care and safety with opioid therapy. 2007 Mar (revised 2010 Jun). NGC:007902
Washington State Agency Medical Directors' Group - Independent Expert Panel. View all guidelines by the developer(s)
17.  
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. 1998 Apr (revised 2013 Jan 22). NGC:009902
American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Professional Association; Heart Rhythm Society - Professional Association. View all guidelines by the developer(s)
18.  
Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. 2008 (revised 2011). NGC:008788
World Health Organization - International Agency. View all guidelines by the developer(s)
19.  
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. 2011 Aug (revised 2013 Sep). NGC:010006
Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by the developer(s)
1-20 of 905   Next >